FdaApplication
NDA 217651
Identifiers
- fda_app_no: NDA217651
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | NDA |
| approval_date | 2023-06-28 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | 1GM/5ML (200MG/ML) | SOLUTION;INTRAVENOUS |
| CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | 500MG/2.5ML (200MG/ML) | SOLUTION;INTRAVENOUS |
2 products